Population pharmacokinetics of lamotrigine adjunctive therapy in infants with partial seizures - Results from LAM20006/7

被引：0
|
作者：
Tompson, D.
Messenheimer, J.
Willwong, R.
Caldwell, P.
机构：
来源：
ANNALS OF NEUROLOGY | 2007年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S144 / S144
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of lamotrigine extended-release adjunctive therapy in subjects with partial seizures: A randomized, double-blind, placebo-controlled study (ARMOR Study)
    Naritoku, Dean
    Warnock, Clay R.
    Messenheimer, John
    NEUROLOGY, 2007, 68 (12) : A124 - A125
  • [32] Efficacy of Brivaracetam (BRV) as Adjunctive Therapy in Partial-Onset (Focal) Seizures Among Patients with Prior Levetiracetam (LEV), Carbamazepine (CBZ), Lamotrigine (LTG), or Topiramate (TPM) Exposure
    Chung, Steve
    Klein, Pavel
    Sperling, Michael
    Diaz, Anyzeila
    Elmoufti, Sami
    Schiemann, Jimmy
    Whitesides, John
    NEUROLOGY, 2016, 86
  • [33] DETERMINATION OF MAXIMUM TOLERATED DOSE (MTD), SAFETY, EFFICACY, AND PHARMACOKINETICS (PK) OF PERAMPANEL, A SELECTIVE AMPA RECEPTOR ANTAGONIST, AS ADJUNCTIVE THERAPY IN SUBJECTS WITH REFRACTORY PARTIAL SEIZURES
    Krauss, Gregory
    Yang, J.
    Biton, V.
    Klapper, J.
    Bar, M.
    Rektor, Ivan
    EPILEPSIA, 2008, 49 : 46 - 47
  • [34] Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: A randomized, multicenter, open-label phase 1 study
    Manitpisitkul, Prasarn
    Shalayda, Kevin
    Todd, Mike
    Wang, Shean S.
    Ness, Seth
    Ford, Lisa
    EPILEPSIA, 2013, 54 (01) : 156 - 164
  • [35] Long-Term Safety of Lacosamide as Adjunctive Therapy in Patients with Uncontrolled Partial-Onset Seizures: Results from a Phase III Open-Label Extension Trial
    Husain, Aatif
    Faught, Raymond Edward
    Chung, Steve
    Isojarvi, Jouko
    McShea, Cindy
    Doty, Pamela
    NEUROLOGY, 2011, 76 (09) : A291 - A291
  • [36] LONG-TERM TREATMENT WITH ADJUNCTIVE LACOSAMIDE FOR PARTIAL-ONSET SEIZURES: AN ANALYSIS OF RESULTS FROM PATIENTS EXPOSED ONLY TO APPROVED DOSES
    Dcruz, N.
    Doty, P.
    Mcshea, C.
    Dimova, S.
    De Backer, M.
    EPILEPSIA, 2012, 53 : 7 - 7
  • [37] Six month efficacy and tolerability results of carisbamate as adjunctive treatment of partial onset seizures: experience from two open label extension studies
    Kalviainen, R.
    Ben-Menachem, E.
    Rosenfeld, W. E.
    Halford, J.
    Wiegand, F.
    Schmitt, J.
    Novak, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 474 - 474
  • [38] USE OF PERAMPANEL, A SELECTIVE, NONCOMPETITIVE AMPA RECEPTOR ANTAGONIST, AS ADJUNCTIVE THERAPY IN PATIENTS WITH REFRACTORY PARTIAL-ONSET SEIZURES: RESULTS OF A GLOBAL PHASE III STUDY
    French, J.
    Elger, C.
    Goldberg-Stern, H.
    Thomson, A.
    Krauss, G. L.
    Labiner, D.
    Squillacote, D.
    Yang, H.
    Kumar, D.
    Laurenza, A.
    EPILEPSIA, 2011, 52 : 10 - 10
  • [39] Pregabalin 300 mg/d is efficacious and well tolerated as adjunctive therapy for partial seizures: Analysis of data from 2 randomized clinical trials
    Spiegel, K.
    Baldinetti, F.
    Huang, S.
    Emir, B.
    EPILEPSIA, 2006, 47 : 175 - 175
  • [40] Pregabalin 300 mg/d is efficacious and well tolerated as adjunctive therapy for partial seizures: Analysis of data from 2 randomized clinical trials
    Baldinetti, F.
    Leon, T.
    Emir, B.
    Whalen, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 212 - 212
12345